Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Johnson & Johnson Private Limited is a multinational healthcare company that focuses on manufacturing pharmaceuticals, medical devices, and consumer health products. It offers a diverse range of products, including over-the-counter medications, surgical instruments, and baby care items, addressing the healthcare needs of individuals and healthcare institutions worldwide.
Johnson & Johnson Private Limited, is an unlisted private company incorporated on 05 September, 1957. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 52.00 cr and the total paid-up capital is INR 14.07 cr.
Read more
** All rupee values in INR crores. Based on March 2025 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ameya Madhav Joshi | 09819116 | 3 years |
| Director | Shilpa Puskarlal Kedia | 10508350 | 1 years |
| Director | Muralidhar Venkata Karanam | 07496715 | 2 years |
| Director | Anuj Virmani | 10274649 | 2 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | 5,574.0 | 2,875.1 | 3,483.3 | 3,947.4 | 4,389.8 |
| Operating profit | 1,446.7 | 515.5 | 604.0 | 818.5 | 886.9 |
| Net profit | 1,028.2 | 1,117.3 | 1,131.0 | 543.3 | 614.3 |
| Gross margin | 70.7 | 55.9 | 54.1 | 54.3 | 54.1 |
| Operating margin | 25.9 | 17.9 | 17.3 | 20.7 | 20.2 |
| Net margin | 18.0 | 30.5 | 26.5 | 13.5 | 13.8 |
| Networth | 3,312.7 | 3,522.8 | 1,937.2 | 2,394.0 | 2,589.0 |
| Borrowings | - | - | - | - | - |
| Assets | 4,663.1 | 5,238.0 | 3,103.8 | 3,818.3 | 3,858.1 |
| Debt to equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current ratio | 2.6 | 2.4 | 2.0 | 2.2 | 2.5 |
| ROE | 31.0 | 31.7 | 58.4 | 22.7 | 23.7 |
| Days payable | 173.0 | 155.0 | 154.0 | 172.0 | 106.0 |
| WC days | 123.0 | 147.0 | 111.0 | 138.0 | 126.0 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 |
| Reserves | 3,298.7 | 3,508.8 | 1,923.1 | 2,379.9 | 2,574.9 |
| Borrowings + | - | - | - | - | - |
| Long term borrowings | - | - | - | - | - |
| Short term borrowings | - | - | - | - | - |
| Trade payables + | 773.1 | 538.5 | 675.2 | 849.5 | 587.3 |
| Days payable | 173.0 | 155.0 | 154.0 | 172.0 | 106.0 |
| Other liabilities + | 1,350.3 | 1,715.2 | 1,166.6 | 1,424.3 | 1,269.1 |
| Other non-current liabilities | 192.5 | 887.1 | 100.0 | 169.9 | 241.2 |
| Other current liabilities | 384.7 | 289.7 | 391.4 | 404.9 | 440.6 |
| Total liabilities | 4,663.1 | 5,238.0 | 3,103.8 | 3,818.3 | 3,858.1 |
| Fixed Assets + | 754.9 | 436.7 | 491.5 | 576.1 | 695.5 |
| Tangible assets | 560.5 | 293.6 | 355.6 | 465.9 | 526.7 |
| CWIP | 121.1 | 135.7 | 132.6 | 108.0 | 167.2 |
| Intangible assets | 73.3 | 7.3 | 3.3 | 2.3 | 1.6 |
| LT loans and advances | - | - | - | - | - |
| Other non-current assets | 873.0 | 2,815.1 | 489.9 | 491.6 | 616.4 |
| Current assets + | 3,035.1 | 1,986.2 | 2,122.4 | 2,750.7 | 2,546.2 |
| Inventories | 819.5 | 602.9 | 793.5 | 709.3 | 725.6 |
| Trade receivables | 842.7 | 709.9 | 839.8 | 905.6 | 1,008.0 |
| Cash and cash equivalents | 1,192.4 | 585.8 | 388.9 | 1,024.5 | 657.9 |
| ST loans and advances | 6.7 | - | - | - | - |
| Other current assets | 173.7 | 87.7 | 100.3 | 111.2 | 154.6 |
| Total assets | 4,663.1 | 5,238.0 | 3,103.8 | 3,818.3 | 3,858.1 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales + | 5,574.0 | 2,875.1 | 3,483.3 | 3,947.4 | 4,389.8 |
| Sales growth % | -13.19 | -48.42 | 21.16 | 13.32 | 11.21 |
| Expenses + | 4,303.9 | 2,462.8 | 2,991.8 | 3,253.1 | 3,623.1 |
| Cost of goods | 1,632.2 | 1,267.9 | 1,600.4 | 1,804.4 | 2,014.3 |
| Employee cost | 788.6 | 455.1 | 632.9 | 642.0 | 769.5 |
| Other costs | 1,706.5 | 636.7 | 646.1 | 682.6 | 719.1 |
| Operating profit + | 1,446.7 | 515.5 | 604.0 | 818.5 | 886.9 |
| Operating margin % | 25.9 | 17.9 | 17.3 | 20.7 | 20.2 |
| Other income | 132.4 | 36.0 | 23.4 | 73.6 | 71.2 |
| Interest | 6.5 | 2.8 | 6.4 | 10.9 | 11.6 |
| Depreciation | 170.2 | 100.4 | 106.1 | 113.2 | 108.6 |
| Exceptional items | -3.0 | - | - | - | - |
| Profit before tax | 1,399.4 | 448.4 | 515.0 | 768.0 | 838.0 |
| Tax | 371.2 | 85.8 | 142.5 | 224.7 | 223.7 |
| Profit - disc. ops | - | 754.7 | 758.6 | - | - |
| Net profit | 1,028.2 | 1,117.3 | 1,131.0 | 543.3 | 614.3 |
| Net margin % | 18.0 | 30.5 | 26.5 | 13.5 | 13.8 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Debt/Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Assets/Equity | 1.4 | 1.5 | 1.6 | 1.6 | 1.5 |
| Liquidity + | |||||
| Current Ratio | 2.6 | 2.4 | 2.0 | 2.2 | 2.5 |
| Quick Ratio | 1.9 | 1.7 | 1.2 | 1.6 | 1.8 |
| Interest Coverage | 222.9 | 186.8 | 95.0 | 75.0 | 76.3 |
| Performance | |||||
| Gross Margin | 70.7 | 55.9 | 54.1 | 54.3 | 54.1 |
| Operating Margin | 25.9 | 17.9 | 17.3 | 20.7 | 20.2 |
| Net Margin | 18.0 | 30.5 | 26.5 | 13.5 | 13.8 |
| Return + | |||||
| Return on Equity | 31.0 | 31.7 | 58.4 | 22.7 | 23.7 |
| Pre-tax ROCE | 48.5 | 26.0 | 32.2 | 34.0 | 35.2 |
| Return on Assets | 22.1 | 21.3 | 36.4 | 14.2 | 15.9 |
| Pre-tax ROIC | 38.5 | 11.8 | 25.7 | 29.5 | 30.1 |
| Efficiency + | |||||
| Days Payable | 173.0 | 155.0 | 154.0 | 172.0 | 106.0 |
| Days Inventory | 183.0 | 174.0 | 181.0 | 143.0 | 131.0 |
| Days Receivable | 55.0 | 90.0 | 88.0 | 84.0 | 84.0 |
| Fixed Asset Turnover | 7.4 | 6.6 | 7.1 | 6.8 | 6.3 |
| Total Asset Turnover | 1.2 | 0.6 | 1.1 | 1.0 | 1.1 |
| Working Capital | |||||
| Cash Conversion Cycle | 65.0 | 109.0 | 115.0 | 55.0 | 109.0 |
| Working Capital Days | 123.0 | 147.0 | 111.0 | 138.0 | 126.0 |
State Bank of India
No. of Loans: 1
Total Amount : 10.0 cr
IDBI Bank Limited
No. of Loans: 2
Total Amount : 3.4 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| KEY TO RICHES INVESTMENT AND LEASING PRIVATE LIMITED | Maharashtra | 1987 | ₹ 5.0 L |
| LOYALTY INVESTMENTS AND ENTERPRISES PRIVATE LIMITED | Maharashtra | 1984 | ₹ 5.0 L |
| SURYALAY INVESTMENT AND TRADING COMPANY PRIVATE LIMITED | Maharashtra | 1981 | ₹ 5.0 L |
| DESHRAJ INVESTMENT AND TRADING COMPANY PRIVATE LIMITED | Maharashtra | 1981 | ₹ 5.0 L |
| NR JET ENTERPRISES PRIVATE LIMITED | Maharashtra | 1981 | ₹ 5.0 L |
Read more
The incorporation date of JOHNSON & JOHNSON PRIVATE LIMITED is 05 September, 1957
The authorized share capital of JOHNSON & JOHNSON PRIVATE LIMITED is INR ₹ 52.0 Cr.
The paid-up capital of JOHNSON & JOHNSON PRIVATE LIMITED is INR ₹ 14.1 Cr.
The registered address of JOHNSON & JOHNSON PRIVATE LIMITED is Higi House, L.B.S. Marg, Mulund West, Mumbai, Mumbai, Mumbai, Maharashtra, India, 400080 - 400080
The CIN number of JOHNSON & JOHNSON PRIVATE LIMITED is U33110MH1957PTC010928.